(Part 2 of a 4 Part Series) -
The application of innovative data driven approaches such as bioinformatics and artificial intelligence to the life science sector has brought about a change in way that biological inventions...more
(Part 1 of a 4 Part Series) -
The application of innovative data driven approaches such as bioinformatics and artificial intelligence to the life science sector has brought about a change in way that biological inventions...more
As previously reported on March 17, 2021, the Federal Circuit affirmed the Patent Trial and Appeal Board (PTAB) decision that the rejected claims of a patent application owned by The Board of Trustees of Leland Stanford...more
On March 11, 2021, in an Opinion by Judge Reyna, along with Chief Judge Prost and Judge Lourie, the Federal Circuit affirmed the Patent Trial and Appeal Board (PTAB) decision that the rejected claims of a patent application...more
On March 5, 2021, bipartisan members of the Senate Committee on the Judiciary Subcommittee on Intellectual Property, Senators Tillis (R-NC), Hirono (D-HI), Cotton (R-AR) and Coons (D-DE), sent a letter to the USPTO’s...more
This 3-part series of posts examines the benefits, disadvantages, and pitfalls concerning nonpublication requests for patent applications. Part 3 of this series focuses on the pitfalls to be aware of when filing...more
Dr. Stephen Thaler created an AI algorithm (named DABUS) that includes multiple neural networks trained in different linguistic subspaces that connect dynamically in a manner based on controlled chaos. DABUS also includes a...more
Dr. Stephen Thaler created an artificial-intelligence algorithm – named Device for the Autonomous Bootstrapping of Unified Sentience (DABUS) – that includes multiple neural networks (each trained in a given linguistic...more
A variety of artificial intelligence (AI) technologies exist and are being used in biopharma (e.g., discovery and development of drugs, optimization of clinical trial design, identification of novel biological targets and...more
Partner Rodney Rothwell has written a 3-part series that examines the benefits, disadvantages, and pitfalls concerning nonpublication requests for patent applications. This second installment focuses on the disadvantages of...more
This 3-part series of posts examines the benefits, disadvantages, and pitfalls concerning nonpublication requests for patent applications. Part 2 of this series focuses on the disadvantages of not publishing a patent...more
This 3-part series of posts examines the benefits, disadvantages, and pitfalls concerning nonpublication requests for patent applications. Part 1 of this series focuses on the general procedure and benefits of not publishing...more
Kilpatrick Townsend’s Kate Gaudry and Rodney Rothwell recently participated in the Association of Corporate Counsel’s National Capital Region’s Summer Series: “Protecting Artificial Intelligence (AI) Innovations – Unique...more
Kilpatrick Townsend’s Rodney Rothwell presented at the 2019 American Association of Pediatric Urologists on the topic of “From Physician Innovator to Physician Patentee.” The presentation provided attendees with a high-level...more